Literature DB >> 31379093

Extended sequencing of vaccine and wild-type capripoxvirus isolates provides insights into genes modulating virulence and host range.

Siddhartha Biswas1, Ryan S Noyce1, Lorne A Babiuk2, Oliver Lung3, Dieter M Bulach4, Timothy R Bowden4, David B Boyle4, Shawn Babiuk3,5, David H Evans1.   

Abstract

The genus Capripoxvirus in the subfamily Chordopoxvirinae, family Poxviridae, comprises sheeppox virus (SPPV), goatpox virus (GTPV) and lumpy skin disease virus (LSDV), which cause the eponymous diseases across parts of Africa, the Middle East and Asia. These diseases cause significant economic losses and can have a devastating impact on the livelihoods and food security of small farm holders. So far, only live classically attenuated SPPV, GTPV and LSDV vaccines are commercially available and the history, safety and efficacy of many have not been well established. Here, we report 13 new capripoxvirus genome sequences, including the hairpin telomeres, from both pathogenic field isolates and vaccine strains. We have also updated the genome annotations to incorporate recent advances in our understanding of poxvirus biology. These new genomes and genes grouped phenetically with other previously sequenced capripoxvirus strains, and these new alignments collectively identified several recurring alterations in genes thought to modulate virulence and host range. In particular, some of the many large capripoxvirus ankyrin and kelch-like proteins are commonly mutated in vaccine strains, while the variola virus B22R-like gene homolog has also been disrupted in many vaccine isolates. Among these vaccine isolates, frameshift mutations are especially common and clearly present a risk of reversion to wild type in vaccines bearing these mutations. A consistent pattern of gene inactivation from LSDV to GTPV and then SPPV is also observed, much like the pattern of gene loss in orthopoxviruses, but, rather surprisingly, the overall genome size of ~150 kbp remains relatively constant. These data provide new insights into the evolution of capripoxviruses and the determinants of pathogenicity and host range. They will find application in the development of new vaccines with better safety, efficacy and trade profiles.
© 2019 Her Majesty the Queen in Right of Canada Transboundary and Emerging Diseases © 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  capripoxvirus; goatpox virus; lumpy skin disease virus; poxvirus; sheeppox virus; virulence

Mesh:

Substances:

Year:  2019        PMID: 31379093     DOI: 10.1111/tbed.13322

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  14 in total

1.  Phylogenomic characterization of historic lumpy skin disease virus isolates from South Africa.

Authors:  Antoinette van Schalkwyk; Pravesh Kara; Livio Heath
Journal:  Arch Virol       Date:  2022-07-06       Impact factor: 2.685

2.  Molecular characterization of the 2018 outbreak of lumpy skin disease in cattle in Upper Egypt.

Authors:  Ahmad M Allam; Mohamed Karam Elbayoumy; Eman H Abdel-Rahman; Ahmed G Hegazi; Tarek Korany Farag
Journal:  Vet World       Date:  2020-07-04

3.  An in-depth bioinformatic analysis of the novel recombinant lumpy skin disease virus strains: from unique patterns to established lineage.

Authors:  Alena Krotova; Olga Byadovskaya; Irina Shumilova; Antoinette van Schalkwyk; Alexander Sprygin
Journal:  BMC Genomics       Date:  2022-05-24       Impact factor: 4.547

Review 4.  Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle.

Authors:  Mahder Teffera; Shawn Babiuk
Journal:  Front Vet Sci       Date:  2019-12-20

Review 5.  Capripoxvirus Infections in Ruminants: A Review.

Authors:  Jihane Hamdi; Henry Munyanduki; Khalid Omari Tadlaoui; Mehdi El Harrak; Ouafaa Fassi Fihri
Journal:  Microorganisms       Date:  2021-04-23

6.  A robust, cost-effective and widely applicable whole-genome sequencing protocol for capripoxviruses.

Authors:  Elisabeth Mathijs; Andy Haegeman; Kris De Clercq; Steven Van Borm; Frank Vandenbussche
Journal:  J Virol Methods       Date:  2022-01-13       Impact factor: 2.014

7.  Genetic Evidence of Multiple Introductions of Lumpy Skin Disease Virus into Saratov Region, Russia.

Authors:  Yuri V Saltykov; Anna A Kolosova; Nadezhda N Filonova; Alexander N Chichkin; Valentina A Feodorova
Journal:  Pathogens       Date:  2021-06-07

8.  Experimental Infection and Genetic Characterization of Two Different Capripox Virus Isolates in Small Ruminants.

Authors:  Janika Wolff; Jacqueline King; Tom Moritz; Anne Pohlmann; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

9.  Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity.

Authors:  Nicola Douglass; Henry Munyanduki; Ruzaiq Omar; Sophette Gers; Paidamwoyo Mutowembwa; Livio Heath; Anna-Lise Williamson
Journal:  Vaccines (Basel)       Date:  2020-11-07

10.  Potential link of single nucleotide polymorphisms to virulence of vaccine-associated field strains of lumpy skin disease virus in South Africa.

Authors:  Antoinette van Schalkwyk; Pravesh Kara; Karen Ebersohn; Arshad Mather; Cornelius Henry Annandale; Estelle Hildegard Venter; David Brian Wallace
Journal:  Transbound Emerg Dis       Date:  2020-09-02       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.